Development and Optimization of Therapeutic Analogues of Anti-TNFα Antibody Infliximab
Crossref DOI link: https://doi.org/10.1134/S0026893318040180
Published Online: 2018-08-03
Published Print: 2018-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yu, X.-J.
Shen, Y.-F.
Dong, J.
Li, T.
Wang, C.
Zhang, Y.-J.
Wang, L.-F.
Meng, Y.-C.
Yang, Y.
Wang, H.-J.
Lei, C.-H.
Hu, S.
Li, B.-H.
Text and Data Mining valid from 2018-07-01
Article History
Received: 28 August 2017
Accepted: 28 October 2017
First Online: 3 August 2018